Published in Immunogenetics on January 01, 1997
Evidence of selection on silent site base composition in mammals: potential implications for the evolution of isochores and junk DNA. Genetics (1999) 2.29
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol (2009) 1.09
PERB11 (MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis. Clin Exp Immunol (2000) 0.76
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature (1997) 8.59
RANK is essential for osteoclast and lymph node development. Genes Dev (1999) 5.85
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 5.69
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (1990) 4.90
Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell (1990) 4.15
Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell (1990) 3.98
Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J (1995) 3.59
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (1988) 3.56
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Cloning, sequence and expression of human interleukin-2 receptor. Nature (1985) 3.02
Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell (1990) 2.95
A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J (1991) 2.85
The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem (1987) 2.78
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J (1991) 2.56
Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci U S A (1989) 2.46
Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem (1988) 2.46
Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med (1989) 2.30
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
Secretion of a transplantation-related antigen. Cell (1983) 2.12
A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol (1997) 2.09
Cloning, sequence and expression of bovine interleukin 1 alpha and interleukin 1 beta complementary DNAs. Mol Immunol (1988) 1.97
Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem (1996) 1.89
Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol (1992) 1.88
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem (1998) 1.86
Murine thymocytes proliferate in direct response to interleukin-7. Blood (1989) 1.86
cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature (1994) 1.85
IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol (1995) 1.84
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol (1999) 1.77
Tissue-specific expression of an unusual H-2 (class I)-related gene. Proc Natl Acad Sci U S A (1982) 1.76
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol (1995) 1.70
Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A (1991) 1.66
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains. J Exp Med (1990) 1.63
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Expression, purification and characterization of recombinant murine granulocyte-macrophage colony-stimulating factor and bovine interleukin-2 from yeast. Gene (1987) 1.50
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. Nature (1982) 1.48
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol (2001) 1.37
The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol (1998) 1.36
Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood (1991) 1.35
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. Proc Natl Acad Sci U S A (1992) 1.28
Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J Biol Chem (1990) 1.26
The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol Rev (2001) 1.24
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Int Immunol (1999) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta. Proc Natl Acad Sci U S A (1987) 1.20
The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol (2000) 1.20
LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev (2000) 1.20
The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood (1995) 1.20
Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc Natl Acad Sci U S A (1994) 1.19
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell (1991) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Cloning, sequence, and expression of bovine interferon-gamma. J Immunol (1986) 1.17
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. Cell Growth Differ (1991) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11
An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11
Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Cloning, sequence, and expression of bovine interleukin 2. Proc Natl Acad Sci U S A (1986) 1.10
Stably transmitted triple-promoter retroviral vectors and their use in transformation of primary mammalian cells. Mol Cell Biol (1988) 1.09
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07
Family studies of IgA deficiency. Immunogenetics (1985) 1.07
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07
Phosphorylation of the human interleukin-2 receptor and a synthetic peptide identical to its C-terminal, cytoplasmic domain. J Biol Chem (1986) 1.07
T-cell growth factor P40 promotes the proliferation of myeloid cell lines and enhances erythroid burst formation by normal murine bone marrow cells in vitro. Blood (1990) 1.05
Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene. Mol Immunol (1988) 1.05
The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05
Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04
Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04
Reconstitution of a functional interleukin (IL)-7 receptor demonstrates that the IL-2 receptor gamma chain is required for IL-7 signal transduction. Eur J Immunol (1995) 1.03
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene (2012) 1.03
Retention of ligand binding activity by the extracellular domain of the IL-1 receptor. J Immunol (1989) 1.02
Further evidence for a common mechanism for shedding of cell surface proteins. FEBS Lett (1997) 1.00
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99
New nomenclature for MHC receptors. Nat Immunol (2001) 0.99
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99